Effect of autologous hematopoietic stem cell transplant on the development of second primary malignancies in multiple myeloma patients

Autologous stem cell transplant (aHSCT) is associated with improved survival for multiple myeloma (MM) patients but may be associated with second primary malignancy (SPM) development. Using the California Cancer Registry linked to statewide hospitalization data, we determined the cumulative incidenc...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosenberg, A. S., Brunson, A., Tuscano, J., Jonas, B. A., Hoeg, R., Wun, T., Keegan, T. H. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791054/
https://www.ncbi.nlm.nih.gov/pubmed/33414400
http://dx.doi.org/10.1038/s41408-020-00400-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791054/
https://www.ncbi.nlm.nih.gov/pubmed/33414400
http://dx.doi.org/10.1038/s41408-020-00400-4

Ejemplares similares